For patients with treatment-resistant depression, the next step after medication and therapy is increasingly interventional psychiatry. Health systems are adding chairs for transcranial magnetic stimulation, moving to accelerated protocols that shrink weeks of treatment into days, and protecting electroconvulsive therapy…
Interventional Psychiatry
The Department of Veterans Affairs is preparing to expand access to psychedelic therapies for veterans with mental health conditions, with as many as 2.1 million potentially benefiting from the treatments, according to an Oct. 25 report from Politico. Andrew Gradison,…
More than a dozen companies are racing to win FDA approval for ketamine-based mental health treatments. Providers warn that one company’s bid could sharply raise the cost of the generic drug, while most of the new products are designed to…
Sacramento, Calif.-based University of California Davis Health has expanded its behavioral health services with an accelerated treatment option for patients with treatment-resistant depression at its Advanced Psychiatric Therapeutics clinic in East Sacramento. The treatment, known as Stanford Accelerated Intelligent Neuromodulation…
Veterans who received the psychedelic drug ibogaine had improvements in post-traumatic stress disorder, depression and anxiety that appeared to last up to one year, a Stanford Medicine study found. The findings, published Aug. 12 in Translational Psychiatry, suggest the treatment…
Advertisement
The Trump administration is considering a larger role for psychedelic substances in medicine, particularly for treating serious mental illnesses, The Hill reported Oct. 3. Here are four things to know: 1. Interest from federal health officials comes as research continues…
The FDA is gathering public feedback as it considers how early-phase clinical trials of ibogaine drug products should be designed. The agency is seeking information on potential patient populations, dosing, safety monitoring and independent oversight, according to an Oct. 5…
For patients who have cycled through therapy and medications without relief, interventional psychiatry has become the next stop, and one of New Hyde Park, N.Y.-based Northwell Health hospitals built its reputation on one of the oldest tools in that kit.…
Scientists from UCSF, UC San Diego and Stanford argued that psychedelic research needs better methods for keeping study participants and researchers unaware of who receives an experimental drug or placebo, the San Francisco Chronicle reported Sept. 16. More than 90%…
Sacramento, Calif.-based UC Davis Health opened an electroconvulsive therapy clinic for patients with serious psychiatric illnesses. The clinic, located on UC Davis Health’s Sacramento campus, provides electroconvulsive therapy for conditions including treatment-resistant depression, bipolar disorder, schizophrenia and catatonia, according to…